Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 273

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

Bladder Cancer, Version 3.2024: Featured Updates to the NCCN Guidelines

Flaig, Thomas W., Spiess, Philippe E., Abern, Michael, Agarwal, Neeraj, Bangs, Rick, Buyyounouski, Mark K., Chan, Kevin, Chang, Sam S., Chang, Paul, Friedlander, Terence, Greenberg, Richard E., Guru, Khurshid A., Herr, Harry W., Hoffman-Censits, Jean, Kaimakliotis, Hristos, Kishan, Amar U., Kundu, Shilajit, Lele, Subodh M., Mamtani, Ronac, Mian, Omar Y., Michalski, Jeff, Montgomery, Jeffrey S., Parikh, Mamta, Patterson, Anthony, Peyton, Charles, Plimack, Elizabeth R., Preston, Mark A., Richards, Kyle, Sexton, Wade J., Siefker-Radtke, Arlene O., Stewart, Tyler, Sundi, Debasish, Tollefson, Matthew, Tward, Jonathan, Wright, Jonathan L., Cassara, Carly J., Gurski, Lisa A.·2024·Journal of the National Comprehensive Cancer Network

Abstract

Bladder cancer, the sixth most common cancer in the United States, is most commonly of the urothelial carcinoma histologic subtype. The clinical spectrum of bladder cancer is divided into 3 categories that differ in prognosis, management, and therapeutic aims: (1) non–muscle-invasive bladder cancer (NMIBC); (2) muscle invasive, nonmetastatic disease; and (3) metastatic bladder cancer. These NCCN Guidelines Insights detail recent updates to the NCCN Guidelines for Bladder Cancer, including changes in the fifth edition of the WHO Classification of Tumours: Urinary and Male Genital Tumours and how the NCCN Guidelines aligned with these updates; new and emerging treatment options for bacillus Calmette-Guérin (BCG)–unresponsive NMIBC; and updates to systemic therapy recommendations for advanced or metastatic disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.6004/jnccn.2024.0024

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 25 references

Metadata

Authors
Flaig, T. W., Spiess, P. E., Abern, M., Agarwal, N., Bangs, R., Buyyounouski, M. K., Chan, K., Chang, S. S., Chang, P., Friedlander, T., Greenberg, R. E., Guru, K. A., Herr, H. W., Hoffman-Censits, J., Kaimakliotis, H., Kishan, A. U., Kundu, S., Lele, S. M., Mamtani, R., Mian, O. Y., Michalski, J., Montgomery, J. S., Parikh, M., Patterson, A., Peyton, C., Plimack, E. R., Preston, M. A., Richards, K., Sexton, W. J., Siefker-Radtke, A. O., Stewart, T., Sundi, D., Tollefson, M., Tward, J., Wright, J. L., Cassara, C. J., & Gurski, L. A.
Venue
Journal of the National Comprehensive Cancer Network
Published
2024-05
Volume
22
Issue
4
Pages
216-225
ISSN
  • 1540-1405 (ISSN-L)
  • 1540-1413
OpenAlex
W4396955712
Cited by
273
References
25
FWCI
97.93
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Bladder Cancer, Version 3.2024: Featured Updates to the NCCN Guidelines. https://app.cochat.ai/papers/10.6004/jnccn.2024.0024
The paper
Flaig, T. W., Spiess, P. E., Abern, M., Agarwal, N., Bangs, R., Buyyounouski, M. K., Chan, K., Chang, S. S., Chang, P., Friedlander, T., Greenberg, R. E., Guru, K. A., Herr, H. W., Hoffman-Censits, J., Kaimakliotis, H., Kishan, A. U., Kundu, S., Lele, S. M., Mamtani, R., . . . Gurski, L. A. (2024). Bladder Cancer, Version 3.2024: Featured Updates to the NCCN Guidelines. Journal of the National Comprehensive Cancer Network. https://doi.org/10.6004/jnccn.2024.0024

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.